Literature DB >> 30264333

Knockdown of miR-429 Attenuates Aβ-Induced Neuronal Damage by Targeting SOX2 and BCL2 in Mouse Cortical Neurons.

Shengqi Fu1,2, Jiewen Zhang3, Shuling Zhang2.   

Abstract

Accumulation of amyloid-β peptide (Aβ) and massive neuronal death due to apoptosis were the essential steps in the pathogenesis of Alzheimer's disease (AD). MiR-429 was reported to play an important role in the pathogenesis of AD. However, the detailed function and underlying molecular mechanism of miR-429 in the pathogenesis of AD remain elusive. Cortical neurons were stimulated with 20 µM of Aβ25-35 for 24 h to construct AD model in vitro. qRT-PCR assay was used to detect the expression of miR-429, and qRT-PCR or western blot analysis were performed to assess the levels of Sex-determining region Y-box 2 (SOX2) and B cell lymphoma-2 protein (BCL2) at mRNA or proteins levels in the AD mouse model and Aβ-induced treated cortical neurons. Luciferase reporter assay and western blot analysis were used to confirm the potential targets of miR-429. CCK-8 assay, flow cytometry analysis, and caspase3 activity assay were used to measure cell viability, cell apoptosis capacity and caspase3 activity, respectively. MiR-429 was upregulated and SOX2 and BCL2 were downregulated in the AD mouse model and Aβ-induced mouse cortical neurons. MiR-429 knockdown attenuated Aβ-induced cytotoxicity in mouse cortical neurons. SOX2 and BCL2 were direct targets of miR-429. Moreover, anti-miR-429-mediated neuroprotective effect was abated by the restoration of SOX2 or BCL2 expression. Knockdown of miR-429 might attenuate Aβ-induced cytotoxicity by targeting SOX2 and BCL2 in mouse cortical neurons, providing a novel prospect in AD therapy.

Entities:  

Keywords:  Alzheimer’s disease (AD); B cell lymphoma-2 protein (BCL2); MiR-429; Sex-determining region Y-box 2 (SOX2)

Mesh:

Substances:

Year:  2018        PMID: 30264333     DOI: 10.1007/s11064-018-2643-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

1.  Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons.

Authors:  E Paradis; H Douillard; M Koutroumanis; C Goodyer; A LeBlanc
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

2.  The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Authors:  Rik Ossenkoppele; Yolande A L Pijnenburg; David C Perry; Brendan I Cohn-Sheehy; Nienke M E Scheltens; Jacob W Vogel; Joel H Kramer; Annelies E van der Vlies; Renaud La Joie; Howard J Rosen; Wiesje M van der Flier; Lea T Grinberg; Annemieke J Rozemuller; Eric J Huang; Bart N M van Berckel; Bruce L Miller; Frederik Barkhof; William J Jagust; Philip Scheltens; William W Seeley; Gil D Rabinovici
Journal:  Brain       Date:  2015-07-02       Impact factor: 13.501

3.  miR-137 attenuates Aβ-induced neurotoxicity through inactivation of NF-κB pathway by targeting TNFAIP1 in Neuro2a cells.

Authors:  Dan He; Jun Tan; Jiewen Zhang
Journal:  Biochem Biophys Res Commun       Date:  2017-06-24       Impact factor: 3.575

Review 4.  The Roles of the Stem Cell-Controlling Sox2 Transcription Factor: from Neuroectoderm Development to Alzheimer's Disease?

Authors:  Golmaryam Sarlak; Bruno Vincent
Journal:  Mol Neurobiol       Date:  2015-02-18       Impact factor: 5.590

5.  The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

Authors:  Marong Fang; Jing Wang; Xiaobing Zhang; Yu Geng; Zhiying Hu; John A Rudd; Shucai Ling; Wei Chen; Shu Han
Journal:  Toxicol Lett       Date:  2011-12-08       Impact factor: 4.372

6.  Osthole reverses beta-amyloid peptide cytotoxicity on neural cells by enhancing cyclic AMP response element-binding protein phosphorylation.

Authors:  Yu Hu; Qingping Wen; Wenbo Liang; Tingguo Kang; Lu Ren; Nan Zhang; Dan Zhao; Dong Sun; Jingxian Yang
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

7.  MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.

Authors:  Juan Li; Lutao Du; Yongmei Yang; Chuanxin Wang; Hui Liu; Lili Wang; Xin Zhang; Wei Li; Guixi Zheng; Zhaogang Dong
Journal:  Cancer Lett       Date:  2012-10-27       Impact factor: 8.679

Review 8.  Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Authors:  Celeste M Karch; Alison M Goate
Journal:  Biol Psychiatry       Date:  2014-05-17       Impact factor: 13.382

9.  MicroRNA-429 decreases the invasion ability of gastric cancer cell line BGC-823 by downregulating the expression of heparanase.

Authors:  Nan Sheng; Lin Zhang; Shaofeng Yang
Journal:  Exp Ther Med       Date:  2017-12-11       Impact factor: 2.447

10.  Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.

Authors:  Sayuri Higaki; Masashi Muramatsu; Akio Matsuda; Kenji Matsumoto; Jun-Ichi Satoh; Makoto Michikawa; Shumpei Niida
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

View more
  3 in total

1.  MiR-429 Inhibits the Angiogenesis of Human Brain Microvascular Endothelial Cells through SNAI2-Mediated GSK-3β/β-Catenin Pathway.

Authors:  Yameng Sun; Shenghao Ding; Yiling Fan; Fei Shen; Qing Dong; Bing Zhao; Yaohua Pan; Jieqing Wan
Journal:  Comput Math Methods Med       Date:  2021-12-20       Impact factor: 2.238

2.  The decreased expression of miR-429 in plasma exosomes after spinal cord injury inhibits neuronal apoptosis by mediating the PTEN/PI3K/Akt pathway.

Authors:  Jiayi Huang; Chunshuai Wu; Guanhua Xu; Yue Sun; Chao Gui; Jiawei Fu; Zhiming Cui; Haiming Huang
Journal:  Ann Transl Med       Date:  2022-01

3.  miRNA-429 suppresses osteogenic differentiation of human adipose-derived mesenchymal stem cells under oxidative stress via targeting SCD-1.

Authors:  Changgong Lan; Lizhen Long; Kegong Xie; Jia Liu; Landao Zhou; Shengcai Pan; Junqing Liang; Zhenyang Tu; Ziran Gao; Yujin Tang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.